We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+21.2%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+494.78%
AUM
$1.89T
AUM Growth
+$231B
Cap. Flow
+$19.1B
Cap. Flow %
1.01%
Top 10 Hldgs %
21.09%
Holding
8,715
New
425
Increased
3,807
Reduced
3,215
Closed
303
Avg Time Held
29.1 quarters
Top 10 Avg Time Held
26.5 quarters
Top 20 Avg Time Held
22.8 quarters

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$2.77B
2
MCK icon
McKesson
MCK
+$2.38B
3
SPCX
SpaceX
SPCX
+$2.3B
4
HONA
Honeywell Aerospace
HONA
+$2.05B
5
AMZN icon
Amazon
AMZN
+$1.37B

Sector Composition

Rank Sector Weight
1 Miscellaneous 26.02%
2 Technology 24.63%
3 Financials 9.78%
4 Healthcare 7.32%
5 Industrials 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LMTL
8051
Direxion Daily LMT Bull 2X ETF
LMTL
$5.09M
$31 ﹤0.01%
1
-1
-50% -$35
2026 Q1
1 quarter
CPHC icon
8052
Canterbury Park Holding Corp
CPHC
$81.4M
$30 ﹤0.01%
1
-1
-50% -$16
2024 Q2
8 quarters
IRVH icon
8053
Global X Interest Rate Volatility & Inflation Hedge ETF
IRVH
$1.11M
$30 ﹤0.01%
1
– –
2026 Q1
1 quarter
ISWN icon
8054
Amplify BlackSwan ISWN ETF
ISWN
$34.4M
$30 ﹤0.01%
1
– –
2023 Q4
10 quarters
LQDW icon
8055
iShares Investment Grade Corporate Bond BuyWrite Strategy ETF
LQDW
$345M
$30 ﹤0.01%
+1
New +$24
2026 Q2
0 quarters
SNPD icon
8056
Xtrackers S&P ESG Dividend Aristocrats ETF
SNPD
$3.16M
$30 ﹤0.01%
1
– –
2023 Q4
10 quarters
KGLD
8057
Kurv Gold Enhanced Income ETF
KGLD
$144M
$30 ﹤0.01%
1
– –
2026 Q1
1 quarter
KSLV
8058
Kurv Silver Enhanced Income ETF
KSLV
$99M
$30 ﹤0.01%
+1
New +$33
2026 Q2
0 quarters
CDX icon
8059
Simplify High Yield ETF
CDX
$326M
$29 ﹤0.01%
1
-93
-99% -$1.98K
2023 Q4
10 quarters
DLPN icon
8060
Dolphin Entertainment
DLPN
$13.7M
$29 ﹤0.01%
25
– –
2023 Q3
11 quarters
SEPQ
8061
STF Tactical Growth & Income ETF
SEPQ
$93.7M
$29 ﹤0.01%
+1
New +$27
2026 Q2
0 quarters
CSAI
8062
Cloudastructure
CSAI
$2.29M
$29 ﹤0.01%
3
-41
-93% -$606
2025 Q1
5 quarters
GXDW
8063
Global X Funds Global X Dorsey Wright Thematic ETF
GXDW
$6.1M
$29 ﹤0.01%
1
– –
2021 Q1
21 quarters
BPAY icon
8064
BlackRock Future Financial and Technology ETF
BPAY
$9.16M
$28 ﹤0.01%
1
– –
2025 Q1
5 quarters
DYLG icon
8065
Global X Dow 30 Covered Call & Growth ETF
DYLG
$4.76M
$28 ﹤0.01%
1
– –
2024 Q1
9 quarters
HFBL icon
8066
Home Federal Bancorp
HFBL
$28 ﹤0.01%
1
– –
2025 Q4
2 quarters
SCC icon
8067
ProShares UltraShort Consumer Discretionary
SCC
$3.22M
$28 ﹤0.01%
1
– –
2025 Q4
2 quarters
SEIX icon
8068
Virtus SEIX Senior Loan ETF
SEIX
$294M
$28 ﹤0.01%
1
– –
2023 Q4
10 quarters
TELA icon
8069
TELA Bio
TELA
$50.1M
$28 ﹤0.01%
+37
New +$30
2026 Q2
0 quarters
YARW
8070
Yarrow Bioscience
YARW
$166M
$28 ﹤0.01%
1
– –
2019 Q3
27 quarters
XXII
8071
22nd Century Group
XXII
$579K
$28 ﹤0.01%
7
+6
+600% +$121
2014 Q1
49 quarters
SER icon
8072
Serina Therapeutics
SER
$50.8M
$28 ﹤0.01%
14
+6
+75% +$11
2018 Q4
30 quarters
BLOX
8073
Nicholas Crypto Income ETF
BLOX
$276M
$28 ﹤0.01%
1
– –
2026 Q1
1 quarter
AKAN icon
8074
Akanda
AKAN
$4.65M
$27 ﹤0.01%
+2
New +$34
2026 Q2
0 quarters
CTXR icon
8075
Citius Pharmaceuticals
CTXR
$13.7M
$27 ﹤0.01%
44
-1,320
-97% -$894
2021 Q1
21 quarters

Similar funds

Morgan Stanley's Q2 2026 Portfolio in Review

As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Morgan Stanley's Q2 2026 filing shows 425 new, 3,807 increased, 3,215 reduced and 303 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.

By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
  • Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
  • Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
  • Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
  • Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
  • Morgan Stanley opened 425 new positions and closed 303 in Q2 2026.
  • Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.